These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11353578)

  • 1. Role of central mineralocorticoid receptors in cardiovascular disease.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Curr Hypertens Rep; 2001 Jun; 3(3):263-9. PubMed ID: 11353578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
    Rahmouni K; Barthelmebs M; Imbs JL; De Jong W
    Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1009-12. PubMed ID: 9749155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?
    Gomez-Sanchez EP
    Trends Endocrinol Metab; 2011 May; 22(5):179-87. PubMed ID: 21429762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central regulation of blood pressure by the mineralocorticoid receptor.
    Gomez-Sanchez EP; Gomez-Sanchez CE
    Mol Cell Endocrinol; 2012 Mar; 350(2):289-98. PubMed ID: 21664417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease.
    Gomez-Sanchez EP
    Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):191-6. PubMed ID: 15202613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis.
    Young MJ; Rickard AJ
    Mol Cell Endocrinol; 2012 Mar; 350(2):248-55. PubMed ID: 21930186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.
    McGraw AP; McCurley A; Preston IR; Jaffe IZ
    Curr Atheroscler Rep; 2013 Jul; 15(7):340. PubMed ID: 23719923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid modulation of central control of blood pressure.
    Gómez Sánchez EP
    Steroids; 1995 Jan; 60(1):69-72. PubMed ID: 7792819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.
    Funder JW
    Am J Cardiovasc Drugs; 2007; 7(3):151-7. PubMed ID: 17610342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of aldosterone.
    Murin J
    Bratisl Lek Listy; 2005; 106(1):3-19. PubMed ID: 15869008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction.
    Caprio M; Mammi C; Jaffe IZ; Zennaro MC; Aversa A; Mendelsohn ME; Fabbri A; Rosano GM
    Curr Pharm Des; 2008; 14(35):3749-57. PubMed ID: 19128227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and cardiovascular disease.
    Carey RM
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):194-8. PubMed ID: 20422779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.
    Young MJ; Funder JW
    J Hypertens; 2002 Aug; 20(8):1465-8. PubMed ID: 12172301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
    Amador CA; Barrientos V; Peña J; Herrada AA; González M; Valdés S; Carrasco L; Alzamora R; Figueroa F; Kalergis AM; Michea L
    Hypertension; 2014 Apr; 63(4):797-803. PubMed ID: 24420551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of the central nervous system in mineralocorticoid hypertension?
    Gómez Sánchez EP
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):374-81. PubMed ID: 1647798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mineralocorticoid receptor antagonists in cardiovascular disease.
    Ferrario CM; Schiffrin EL
    Circ Res; 2015 Jan; 116(1):206-13. PubMed ID: 25552697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms.
    Fu Y; Vallon V
    Nephron Physiol; 2014; 128(1-2):8-16. PubMed ID: 25376899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do central mineralocorticoid receptors modulate blood pressure?
    Funder JW
    Am J Physiol Regul Integr Comp Physiol; 2005 Feb; 288(2):R356-7. PubMed ID: 15637173
    [No Abstract]   [Full Text] [Related]  

  • 20. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.
    DuPont JJ; Jaffe IZ
    J Endocrinol; 2017 Jul; 234(1):T67-T82. PubMed ID: 28634267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.